U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06908057) titled 'Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)' on March 12.
Brief Summary: The purpose of this study is to identify people with T1D or celiac disease (CD) early in the course of their disease and to improve the methods of screening for these diseases.
Study Start Date: March 11, 2024
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes
Celiac Disease
Intervention:
OTHER: Blood Draw
We will draw blood to measure islet-related autoantibodies and celiac disease markers with a combined research method, blood sugar, C-peptide (an indicator of insulin production ...